Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)
Clinical trial NCT04655625 · COMPLETED
Trial details
- NCT number
- NCT04655625
- Sponsor
- AnGes, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2021-04-02
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.